1200 mutations away from RATG-13 is how significant exactly? I will propose that it is not particularly significant. One virus I work with, I have 14 variants ranging from 300 to 500 base-pair differences. That is from passing in a laboratory only. I have one variant that has a 14000 BP deletion! (
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217056/#mmi144... TABLE S2) However, it is noteworthy for that reason. That said, these are dsDNA viruses with comparatively much slower mutation rates. 1200-base differences are almost nothing.
You're comparing apples and oranges. 14 mutational sites across a virus with 17k ssDNA genome is not comparable to RATG-13 vs SARS-2, which have not just 1200 mutations different, they're spread out over HUNDREDS of SNPs.
That's the important comparator. And why it will take so long to mutate one into the other by natural mutation rates.
>The two non-canonical arginines don't make it less likely?
Not particularly. CGG exists in MERS 15 times. NL63, 29 times. It even exists twice in a row in Human coronavirus 229E. Throughout all of the known alphacoronaviruses (94 described) CGG exists 1575 times. In betacoronaviruses, it exists more times than my processor can count without hanging, and I believe it tops out at 9,999 events.
I just ran blastn to figure that out. Using these datasets: https://www.ncbi.nlm.nih.gov/datasets/coronavirus/genomes/
Why is it so unlikely that synonymous mutational drift over the course of 70 years of infections in millions of viral generations could create these arginine codons that are not the most optimized but still work in the mammals this virus infects? CGG works. It makes an arginine when this virus infects its host.
Why couldn't it be a recombination event between SARS-2 and one of the known coronaviruses with an extremely similar cleavage site? We know already coronaviruses have recombined with viruses totally outside of their family on occasion: https://www.virology.ws/2016/10/27/genome-recombination-acro...